CYCLOSPORIN-A, A POWERFUL IMMUNOSUPPRESSANT INVIVO AND INVITRO IN THE DOG, FAILS TO INDUCE TOLERANCE
CYCLOSPORIN-A, A POWERFUL IMMUNOSUPPRESSANT INVIVO AND INVITRO IN THE DOG, FAILS TO INDUCE TOLERANCE
复制标题
DOI:
10.1097/00007890-198003000-00014
复制
发表时间:
1980-01-01
期刊:
影响因子:
6.2
通讯作者:
THOMAS, ED
中科院分区:
文献类型:
--
作者:
DEEG, HJ;STORB, R;THOMAS, ED
Cyclosporin A (Cy A) was evaluated in dogs for its effectiveness in prolonging skin graft survival from DLA-nonidentical, unrelated donors and in reversing rejection crises. Cy A was given in courses of 21 days. Dogs were monitored in vitro with mixed leukocyte cultures (MLC) and indirect cell-mediated lympholysis (CML). Grafts remained viable throughout the first Cy A course. Signs of rejection developed on days 27-33. These were reversed in 3 of 4 dogs by a 2nd course of Cy A. Second and third rejection crises following subsequent courses of Cy A were also reversed. After stopping Cy A 1st-set grafts were ultimately rejected, by days 83-114. Second-set graft survival was also prolonged by Cy A and rejection crises were reversed by additional Cy A courses. After stopping Cy A 2nd-set grafts were rejected. Median graft survival in 35 untreated dogs was 12 days for the 1st and 8 days for the 2nd set (24 dogs). Lymphocytes from all Cy A-treated dogs showed normal reactivity in MLC and CML against lymphocytes from skin graft donors and unrelated dogs when set up in normal serum. In serum from Cy A-treated dogs, MLC and CML reactivities were abrogated. Similar suppression was seen with Cy A added in vitro. Mitogen-induced blastogenesis was mildly suppressed by serum from Cy A-treated dogs. Cy A is a powerful immunosuppressant in the dog in vivo and in vitro but fails to induce persistent immunological unresponsiveness. Immunosuppression appears to depend upon the continued presence of the drug.